<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Avenue Therapeutics Inc — News on 6ix</title>
    <link>https://6ix.com/company/avenue-therapeutics-inc</link>
    <description>Latest news and press releases for Avenue Therapeutics Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 23 Feb 2026 13:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/avenue-therapeutics-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835498878dffbe2df0e44b9.webp</url>
      <title>Avenue Therapeutics Inc</title>
      <link>https://6ix.com/company/avenue-therapeutics-inc</link>
    </image>
    <item>
      <title>Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease</title>
      <link>https://6ix.com/company/avenue-therapeutics-inc/news/avenue-therapeutics-enters-into-exclusive-worldwide-license-agreement-for-atx-04-for-the-treatment-of-pompe-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/avenue-therapeutics-inc/news/avenue-therapeutics-enters-into-exclusive-worldwide-license-agreement-for-atx-04-for-the-treatment-of-pompe-disease</guid>
      <pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
      <description>Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease.</description>
    </item>
    <item>
      <title>Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics</title>
      <link>https://6ix.com/company/avenue-therapeutics-inc/news/avenue-therapeutics-announces-acquisition-of-subsidiary-baergic-bio-by-axsome-therapeutics</link>
      <guid isPermaLink="true">https://6ix.com/company/avenue-therapeutics-inc/news/avenue-therapeutics-announces-acquisition-of-subsidiary-baergic-bio-by-axsome-therapeutics</guid>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <description>Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics.</description>
    </item>
  </channel>
</rss>